Biohaven (BHVN) Cash from Financing Activities (2021 - 2026)

Biohaven (BHVN) has 6 years of Cash from Financing Activities data on file, last reported at $179.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 48413.82% year-over-year to $179.0 million; the trailing twelve-month figure through Mar 2026 stood at $617.8 million (down 8.44% YoY), and the FY2025 full-year result was $439.1 million, down 35.21% from the prior year.
• Cash from Financing Activities declined to $179.0 million in Q1 2026, from $188.8 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $530.2 million in Q4 2022 to a low of -$39.7 million in Q3 2023.
• A 5-year average of $133.8 million and a median of $86.8 million in 2022 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities sank 131.09% in 2023 and jumped 48413.82% in 2026, its largest moves.
• Tracing BHVN's Cash from Financing Activities over 5 years: stood at $530.2 million in 2022, then slumped by 53.74% to $245.2 million in 2023, then advanced by 11.26% to $272.9 million in 2024, then plunged by 30.81% to $188.8 million in 2025, then fell by 5.18% to $179.0 million in 2026.
• Business Quant data shows BHVN's Cash from Financing Activities at $179.0 million in Q1 2026, $188.8 million in Q4 2025, and $122000.0 in Q3 2025.